BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35999392)

  • 1. ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts.
    Yan M; Komatsu N; Muro R; Huynh NC; Tomofuji Y; Okada Y; Suzuki HI; Takaba H; Kitazawa R; Kitazawa S; Pluemsakunthai W; Mitsui Y; Satoh T; Okamura T; Nitta T; Im SH; Kim CJ; Kollias G; Tanaka S; Okamoto K; Tsukasaki M; Takayanagi H
    Nat Immunol; 2022 Sep; 23(9):1330-1341. PubMed ID: 35999392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
    Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE
    J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program.
    Nakerakanti SS; Kapanadze B; Yamasaki M; Markiewicz M; Trojanowska M
    J Biol Chem; 2006 Sep; 281(35):25259-69. PubMed ID: 16829517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDR2-CYR61-MMP1 Signaling Pathway Promotes Bone Erosion in Rheumatoid Arthritis Through Regulating Migration and Invasion of Fibroblast-Like Synoviocytes.
    Huang TL; Mu N; Gu JT; Shu Z; Zhang K; Zhao JK; Zhang C; Hao Q; Li WN; Zhang WQ; Liu NN; Zhang Y; Zhang W; Xue XC; Zhang YQ
    J Bone Miner Res; 2017 Feb; 32(2):407-418. PubMed ID: 27653023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETS1 polymorphism rs73013527 in relation to serum RANKL levels among patients with RA.
    Yang B; Luo L; Chen L; Niu Q; Zhang J; Xu H; Wu Y; Huang Z
    Medicine (Baltimore); 2021 Feb; 100(5):e24562. PubMed ID: 33592912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation.
    Kabbout M; Dakhlallah D; Sharma S; Bronisz A; Srinivasan R; Piper M; Marsh CB; Ostrowski MC
    PLoS One; 2014; 9(6):e100693. PubMed ID: 24968297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis.
    Wen H; Liu Y; Li J; Wei D; Liu D; Zhao F
    Clin Exp Rheumatol; 2018; 36(5):798-805. PubMed ID: 29465363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
    Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y
    Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL production in rheumatoid arthritis.
    Kim HR; Kim KW; Kim BM; Lee KA; Lee SH
    Korean J Intern Med; 2019 Jan; 34(1):210-219. PubMed ID: 28286938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proinflammatory cytokines IL-1beta and TNF-alpha induce the expression of Synoviolin, an E3 ubiquitin ligase, in mouse synovial fibroblasts via the Erk1/2-ETS1 pathway.
    Gao B; Calhoun K; Fang D
    Arthritis Res Ther; 2006; 8(6):R172. PubMed ID: 17105652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis.
    Ledesma-Colunga MG; Adán N; Ortiz G; Solís-Gutiérrez M; López-Barrera F; Martínez de la Escalera G; Clapp C
    Arthritis Res Ther; 2017 May; 19(1):93. PubMed ID: 28506283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
    van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
    Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis.
    Ainola M; Mandelin J; Liljeström M; Konttinen YT; Salo J
    Clin Exp Rheumatol; 2008; 26(2):240-6. PubMed ID: 18565244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical stretch regulates the expression of matrix metalloproteinase in rheumatoid arthritis fibroblast-like synoviocytes.
    Wang P; Yang L; You X; Singh GK; Zhang L; Yan Y; Sung KL
    Connect Tissue Res; 2009; 50(2):98-109. PubMed ID: 19296301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of matrix metalloproteinase and TIMP genes in fibroblasts derived from Ets-1 knock-out mice compared to wild-type mouse fibroblasts.
    Hahne JC; Fuchs T; El Mustapha H; Okuducu AF; Bories JC; Wernert N
    Int J Mol Med; 2006 Jul; 18(1):153-9. PubMed ID: 16786167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
    Romas E; Gillespie MT; Martin TJ
    Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ets1 is an effector of the transforming growth factor beta (TGF-beta ) signaling pathway and an antagonist of the profibrotic effects of TGF-beta.
    Czuwara-Ladykowska J; Sementchenko VI; Watson DK; Trojanowska M
    J Biol Chem; 2002 Jun; 277(23):20399-408. PubMed ID: 11919190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation.
    Zhang LM; Zhou JJ; Luo CL
    Arthritis Res Ther; 2018 Oct; 20(1):219. PubMed ID: 30285829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erosive arthritis.
    Schett G
    Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S2. PubMed ID: 17634141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells.
    Ko SY
    Arch Oral Biol; 2012 Dec; 57(12):1623-32. PubMed ID: 22795564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.